Research Publications

Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.

Hart RG, Bhatt DL, Hacke W, Fox KA, Hankey GJ, Berger PB, Hu T, Topol EJ, CHARISMA Investigators

Future use of genomics in coronary artery disease.

Damani SB, Topol EJ

Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.

Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew DP, Bittl JA, Topol EJ, Manoukian SV

Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rate.

Inrig JK, Gillespie BS, Patel UD, Briley LP, She L, Easton JD, Topol E, Szczech LA

Is there a genetic basis for acute coronary syndrome?

Patay BA, Topol EJ

Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.

Singh M, White J, Hasdai D, Hodgson PK, Berger PB, Topol EJ, Califf RM, Holmes DR Jr

Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V.

Reynolds HR, Farkouh ME, Lincoff AM, Hsu A, Swahn E, Sadowski ZP, White JA, Topol EJ, Hochman JS, GUSTO V Investigators

Validity of reported genetic risk factors for acute coronary syndrome.

McCarthy JJ, Topol EJ

Population attributable fraction: its implications for genetic epidemiology and illness prevention.

Karp I, Topol E, Pilote L

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL